{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:23:25Z","timestamp":1757312605567},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00105-013-2744-5","type":"journal-article","created":{"date-parts":[[2014,2,18]],"date-time":"2014-02-18T11:16:57Z","timestamp":1392722217000},"page":"133-145","source":"Crossref","is-referenced-by-count":10,"title":["Botulinumtoxin in der Dermatologie"],"prefix":"10.1007","volume":"65","author":[{"given":"W.G.","family":"Philipp-Dormston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,16]]},"reference":[{"key":"2744_CR1","first-page":"83","volume":"16","author":"Carruthers","year":"1990","unstructured":"Carruthers A, Carruthers J (1990) The treatment of glabellar furrows with botulinum A exotoxin. J Dermatol Surg Oncol 16:83","journal-title":"J Dermatol Surg Oncol"},{"key":"2744_CR2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/14764170701411470","volume":"9","author":"Carruthers","year":"2007","unstructured":"Carruthers J, Carruthers A (2007) The evolution of botulinum neurotoxin type A for cosmetic applications. J Cosmet Laser Ther 9:186\u2013192","journal-title":"J Cosmet Laser Ther"},{"key":"2744_CR3","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1517\/14656566.8.8.1059","volume":"8","author":"DeBoulle","year":"2007","unstructured":"DeBoulle K (2007) Botulinum neurotoxin type A in facial aesthetics. Expert Opin Pharmacother 8:1059\u20131072","journal-title":"Expert Opin Pharmacother"},{"key":"2744_CR4","unstructured":"FDA (2008) Information for Healthcare Professionals: OnabotulinumtoxinA (marketed as Botox\/Botox Cosmetic), AbobotulinumtoxinA (marketed as Dysport) and RimabotulinumtoxinB (marketed as Myobloc). FDA, Silver Spring. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/ucm174949. Zugegriffen: 03.12.2013"},{"key":"2744_CR5","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaad.2009.06.040","volume":"61","author":"Brin","year":"2009","unstructured":"Brin MF, Boodhoo TI, Pogoda JM et al (2009) Safety and tolerability of onabotulinumtoxin A in the treatment of facial lines: a meta-analysis of individual patient data from global clinical registration studies in 1678 participants. J Am Acad Dermatol 61:961\u2013970","journal-title":"J Am Acad Dermatol"},{"key":"2744_CR6","doi-asserted-by":"crossref","unstructured":"Philipp-Dormston WG, Bergfeld D, Sommer B et al (2013) Konsensusempfehlungen zur Behandlung mit Onabotulinumtoxin A in der \u00e4sthetischen Medizin. J Dtsch Dermatol Ges [Suppl S1] 11:1\u201342","DOI":"10.1111\/ddg.12013"},{"key":"2744_CR7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1473-2165.2010.00544.x","volume":"10","author":"Raspaldo","year":"2011","unstructured":"Raspaldo H, Baspeyras M, Bellity P et al (2011) Upper- and mid-face anti-aging treatment and prevention using onabotulinumtoxin A: the 2010 multidisciplinary French consensus \u2013 part 1. J Cosmet Dermatol 10:36\u201350","journal-title":"J Cosmet Dermatol"},{"key":"2744_CR8","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/j.1468-3083.2010.03631.x","volume":"24","author":"Ascher","year":"2010","unstructured":"Ascher B (2010) International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit). Part I: Upper facial wrinkles. J Eur Acad Dermatol Venereol 24:1278\u20131284","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2744_CR9","doi-asserted-by":"crossref","unstructured":"Carruthers J, Fagien S, Matarasso SL et al (2004) Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg [Suppl 6] 114:1S\u201322S","DOI":"10.1097\/01.PRS.0000144795.76040.D3"},{"key":"2744_CR10","unstructured":"Deutsche Dermatologische Gesellschaft (2012) \u00c4sthetische Botulinumtoxin-Therapie. AWMF-Leitlinienregisternummer 013\/077. AWMF, D\u00fcsseldorf. http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/013-077l_S1_\u00c4sthetische_Botulinumtoxin_Therapie_2012-11.pdf. Zugegriffen: 03.12.2013"},{"key":"2744_CR11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/MMBR.56.1.80-99.1992","volume":"56","author":"Schantz","year":"1992","unstructured":"Schantz EJ, Johnson EA (1992) Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol Rev 56:80\u201399","journal-title":"Microbiol Rev"},{"key":"2744_CR12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF00839205","volume":"239","author":"Hambleton","year":"1992","unstructured":"Hambleton P (1992) Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use. J Neurol 239:16\u201320","journal-title":"J Neurol"},{"key":"2744_CR13","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1111\/j.1468-1331.2007.01683.x","volume":"14","author":"Pickett","year":"2007","unstructured":"Pickett A (2007) The protein load of therapeutic botulinum toxins. Eur J Neurol 14:e11","journal-title":"Eur J Neurol"},{"key":"2744_CR14","unstructured":"Mohindru A, Bulloch S, Kronfeld N et al (2013) Analysis of clinical and non-clinical, peer-reviewed published studies investigating the use of commercially available botulinum toxins: An online literature review (Poster). 2. International Congress on Treatment of Dystonie, Hannover"},{"key":"2744_CR15","unstructured":"Heckmann M, Rzany B (2002) Botulinumtoxin in der Dermatologie. Grundlagen und praktische Anwendung, 1.\u00a0Aufl. Urban & Vogel, M\u00fcnchen, S\u00a022\u201325"},{"key":"2744_CR16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature12732","volume":"505","author":"Benoit","year":"2014","unstructured":"Benoit RM, Frey D, Hilbert M et al (2014) Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A. Nature 505:108\u2013111","journal-title":"Nature"},{"key":"2744_CR17","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/mds.20205","volume":"19","author":"Newman","year":"2004","unstructured":"Newman WJ, Davis TL, Padaliya BB et al (2004) Botulinum toxin type A therapy during pregnancy (Erratum in: Mov Disord 2005; 20:121). Mov Disord 19:1384\u20131385","journal-title":"Mov Disord"},{"key":"2744_CR18","first-page":"1089","volume":"15","author":"Carruthers","year":"2003","unstructured":"Carruthers J, Lowe NJ, Menter MA et al (2003) Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines. Plast Reconstr Surg 15:1089\u20131098","journal-title":"Plast Reconstr Surg"},{"key":"2744_CR19","first-page":"101","volume":"5","author":"De","year":"2010","unstructured":"De Boulle K, Fagien S, Sommer B et al (2010) Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction. Clin Interv Aging 5:101\u2013118","journal-title":"Clin Interv Aging"},{"key":"2744_CR20","doi-asserted-by":"crossref","unstructured":"Carruthers A, Carruthers J, Lei X et al (2010) Onabotulinumtoxin A treatment of mild glabellar lines in repose. Dermatol Surg [Suppl 4] 36:2168\u20132171","DOI":"10.1111\/j.1524-4725.2010.01708.x"},{"key":"2744_CR21","unstructured":"Carruthers A, Carruthers J (1994) Botulinumtoxin A in the treatment of glabellar frown lines and other facial wrinkles. In: Jankovic J, Haller M (Hrsg) Therapy with botulinum toxin. Decker, New York, S\u00a0577\u2013595"},{"key":"2744_CR22","unstructured":"Carruthers A (2013) Efficacy and safety of onabotulinumtoxin A for the treatment of crow\u2032s feet lines. IMCAS Annual Meeting 2013, Paris"},{"key":"2744_CR23","first-page":"16","volume":"3","author":"Philipp-Dormston","year":"2011","unstructured":"Philipp-Dormston WG (2011) Augenbrauenlifting. Wie sieht die perfekte Braue aus? Asthet Dermatol Kosmetol 3:16\u201317","journal-title":"Asthet Dermatol Kosmetol"},{"key":"2744_CR24","first-page":"39","volume":"31","author":"Philipp-Dormston","year":"2010","unstructured":"Philipp-Dormston WG (2010) Gesichtskonturierung mit Botulinumtoxin: square face syndrome und full face BTX. Kosmet Med 31:39","journal-title":"Kosmet Med"},{"key":"2744_CR25","unstructured":"W\u00f6rle B, Heckmann M, Rapprich S (2012) Definition und Therapie der prim\u00e4ren Hyperhidrose. AWMF-Leitlinienregisternummer 013\/059. AWMF, D\u00fcsseldorf. http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/013-059l_S1_prim\u00e4re_Hyperhidrose_Definition_Therapie_2012-01.pdf. Zugegriffen:28.11.2013"},{"key":"2744_CR26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM200102153440704","volume":"344","author":"Heckmann","year":"2001","unstructured":"Heckmann M, Ceballos-Baumann A, Plewig G et al (2001) Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med 344:488\u2013493","journal-title":"N Engl J Med"},{"key":"2744_CR27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00105-012-2333-z","volume":"63","author":"Hosp","year":"2012","unstructured":"Hosp C, Naumann MK, Hamm H (2012) Botulinumtoxin bei fokaler Hyperhidrose. Ein aktueller \u00dcberblick. Hautarzt 63:469\u2013476","journal-title":"Hautarzt"},{"key":"2744_CR28","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1365-2133.2000.03839.x","volume":"143","author":"Kinkelin","year":"2000","unstructured":"Kinkelin I, Hund M, Naumann M et al (2000) Effective treatment of frontal hyperhidrosis with botulinum toxin A. Br J Dermatol 143:824\u2013827","journal-title":"Br J Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-013-2744-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-013-2744-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-013-2744-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T13:14:11Z","timestamp":1597497251000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-013-2744-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["2744"],"URL":"https:\/\/doi.org\/10.1007\/s00105-013-2744-5","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}